Vitalgen closed 200 million RMB Series A+ funding round

（Shanghai, China, October 16, 2021），Shanghai Vitalgen BioPharma Co., Ltd. has raised 200 million RMB Series A+ funding round. The financing is led by Hillhouse. Other new and existing investors include Cenova Capital, Lingang Life Blue Bay Capital. IDG and Loyal Valley Capital.  

 The funding will be used to continue developing our technology platforms and strengthening research pipelines.